Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Comment by Goldnboy1on May 01, 2022 4:47pm
138 Views
Post# 34646262

RE:Told you so, didn't I

RE:Told you so, didn't I

The company just reposted their investor deck.

In it is a planned event calendar. 

Im told there was a delay in development to ensure a conjugation patent had the best protection.  That's now complete. 

Due to this the company can now file for new linker IP. The planned events calendar is showing the completion of a linker project in May it appears. 

Typically when this company has invented ip in the past they have ran pretty hard. So for investors looking for short term 2x-5x returns. This is likely a very good place to find them short term. 

The current CEO is Dr. Ben Krantz. He hasn't failed at anything yet. He is doing his thing for the first time ever. So your statement is false.

<< Previous
Bullboard Posts
Next >>